FOSUN HEALTH Logo

Goiter Diagnosis

catalogue

Goiter Diagnosis

Goiter Diagnosis

The assessment of a goiter is standardised, and its whole design answers three questions at once. The first is how the gland is working, because an enlarged gland may be producing too much hormone, too little, or exactly the right amount, and the neck cannot tell you which. The second is what shape the gland has taken, because a smooth enlargement and a gland made up of nodules are followed in different ways. The third is whether anything inside needs to be looked at on its own terms, because a goiter containing a nodule is assessed nodule by nodule rather than by its overall size.

The clinical examination: what the hand is feeling for

Before any test is ordered, the neck is examined, and what is found there directs everything that follows:

  • Is it the thyroid at all — the gland is identified by its position and by rising when the patient swallows. A swelling that does not move with swallowing is coming from elsewhere.
  • Smooth or nodular — a gland that feels uniformly enlarged is described as diffuse; one in which distinct lumps can be felt is described as nodular. This single distinction changes the tests that follow.
  • Each nodule described separately — where nodules are present, their size, firmness and mobility are recorded individually, because each is characterised on its own features.
  • The neighbours — the lymph nodes of the neck are felt, the position of the windpipe is noted and the voice is listened to. An examination that stops at the thyroid is incomplete.
  • With the arms raised — the neck is re-examined with both arms above the head, because a large gland can be drawn into the chest in that position and produce compression the resting examination misses.

What the examination cannot do is decide how the gland is working or what is inside it. It sets the direction, and the tests answer the questions the hand has raised.

Thyroid function tests: the question the neck cannot answer

Blood tests come first, and they answer the question that governs the whole plan:

  • TSH is the primary test — thyroid stimulating hormone rises or falls in response to the amount of thyroid hormone circulating. A normal TSH with normal free T4 means the gland is working normally whatever its size.
  • Free T4, and free T3 where needed — the actual hormone levels confirm the direction the TSH is pointing and quantify an abnormality rather than merely detecting it.
  • A suppressed TSH points to overactivity — when the gland produces too much hormone the pituitary stops driving it and TSH falls, often to undetectable levels. This is what separates a toxic from a non-toxic goiter.
  • A raised TSH points to underactivity — when the gland cannot keep up, the pituitary drives it harder and TSH rises, the pattern typically associated with autoimmune thyroiditis.
  • Occasionally TSH looks normal while the gland is overactive — subclinical overactivity, with hormone levels at the top of the range and TSH low but not suppressed, is still a finding that changes monitoring.

Why this comes before imaging. Because treatment starts with the function: a gland producing too much hormone is affecting the heart and the bones for as long as the levels stay high, whatever it looks like on a scan. Size can wait for the next test.

Ultrasound: the test that describes the gland

Ultrasound is the imaging test for the thyroid itself, and it answers the structural questions the blood tests cannot:

  • Its size, in measured terms — each lobe is measured and the gland’s volume calculated, giving a number that can be compared with the same number a year from now. This is what makes monitoring meaningful.
  • Diffuse or nodular — the scan confirms what the examination suspected and shows nodules too small or too deep to feel, including ones that alter the plan precisely because they were not palpable.
  • Each nodule characterised — nodules are described by standard features: how dark or bright, whether solid, cystic or mixed, their edges and shape, and any calcification. Those features combine into a category stating how likely a needle test is to be needed.
  • The lymph nodes of the neck — the nodes are scanned alongside the gland, because the two are assessed together whenever a nodule raises a question.
  • Diffuse changes of autoimmune disease — in Hashimoto’s thyroiditis the gland has a characteristic uneven texture, which supports the antibody results rather than replacing them.

What ultrasound does not tell you. It cannot measure hormone levels, and it cannot tell you what a nodule is made of — only what it looks like.

Antibodies: finding the reason the gland grew

Where an autoimmune cause is suspected, antibody tests identify it — and the two autoimmune diseases that enlarge the thyroid push in opposite directions:

  • Thyroid peroxidase antibodies — found in most people with Hashimoto’s thyroiditis, the commonest cause of an enlarged gland with underactive hormone levels. Their presence supports the diagnosis rather than establishing it alone.
  • Thyroglobulin antibodies — frequently found alongside thyroid peroxidase antibodies and useful in the same direction; the two are usually requested together.
  • TSH-receptor antibodies — the antibodies of Graves’ disease, where the gland is both enlarged and overactive, because they stimulate it directly rather than damaging it.
  • Antibodies can be present without symptoms — a person may carry thyroid antibodies with normal hormone levels and a slightly enlarged gland, which changes monitoring rather than triggering treatment.

Why the cause is worth identifying. Two glands of the same size, one enlarged by an iodine shortage and one by autoimmune disease, require different things: an iodine deficiency is corrected, an autoimmune process is tracked.

Uptake scanning and needle tests: what each is for

Two further tests are used selectively rather than routinely, and each has a specific question to answer:

  • The uptake scan, in an overactive gland — a small amount of tracer is given and its distribution imaged. Diffuse uptake points to Graves’ disease; uptake concentrated in one nodule with the rest suppressed points to a single overactive nodule, and the two are treated differently.
  • A hot nodule is reassuring in one specific sense — nodules that take up the tracer avidly and are overactive are very rarely malignant, which is the reason the scan is ordered: it settles a question that would otherwise need a needle.
  • Fine needle aspiration, for a nodule whose features call for it — a thin needle samples cells under ultrasound guidance. It is not used for the gland as a whole and not for every nodule, but where the features, size or growth of a particular nodule warrant it.
  • Results are reported in standard categories — from clearly benign through indeterminate to suspicious, with the indeterminate categories carrying defined next steps, so that the same finding leads to the same decision regardless of who reads it.
  • CT or MRI, where the gland is very large — used to map how far the gland descends behind the breastbone and how it relates to the windpipe, before any treatment decision is made.

What each test is not for. The uptake scan is not a general test of thyroid disease; fine needle aspiration does not diagnose an overactive gland.

Reading the results together as one plan

The results are combined into a single conclusion, and there are essentially three of them. Which applies decides everything that follows:

  • The gland can be monitored — the usual conclusion: function normal, enlargement smooth or nodular without suspicious features, nothing pressing. It comes with a defined schedule of blood tests and ultrasound and a documented baseline.
  • The function needs correcting — the gland is overactive or underactive, whatever its size. Treatment is aimed at the hormone levels first, because those are what affect the heart, the bones and the metabolism.
  • The gland needs to be dealt with structurally — it is compressing the windpipe, the gullet or the nerve to the voice, extends behind the breastbone, or contains a nodule whose features or needle result require it.
  • More than one can apply at once — an overactive gland that is also pressing is treated for both, and the order is a clinical judgement made with the patient. Reading the results as a single label is the commonest way to misunderstand them.

When the results disagree. Disagreement between the steps is not a failure of the assessment but one of its products, and it is the situation in which the question is pursued further.

Frequently Asked Questions

Why do I need blood tests if the problem is clearly in my neck?

Because the size of the gland and the amount of hormone it produces are separate things, and the neck cannot show the second. An enlarged gland may be working normally, producing too much, or producing too little, and those three situations are treated in completely different ways. The blood test is done first because it decides which of the three you are in.

What is the difference between a thyroid ultrasound and a thyroid scan?

They answer different questions. An ultrasound uses sound waves to show the gland’s size, structure and the appearance of any nodules, and is used in almost every assessment. An uptake scan uses a small amount of tracer to show how the gland is functioning — whether activity is spread evenly or concentrated in one nodule — and is used mainly when the gland is overactive, because that distinction changes the treatment.

If my ultrasound shows nodules, do they all need a needle test?

No. Needle testing is selective. Each nodule is graded by its ultrasound features and its size, and only those whose features or dimensions call for it are sampled. Many nodules — particularly small ones with unremarkable features — are simply documented and compared at the next ultrasound.

How often should a goiter be reassessed?

The interval follows what was found rather than a fixed rule. A gland with normal function, no suspicious nodule and no compression is usually reviewed with blood tests and ultrasound at intervals of roughly a year, adjusted for the individual. A gland being treated for over- or underactivity is monitored according to the levels, which may mean checks every few weeks while treatment is adjusted and much less often once stable.

Send your results, and have them read as one plan

Send any thyroid blood results you have, ultrasound images and reports — the images themselves if you have them, not only the written report — and a list of your medication. A written assessment covering which of the three conclusions applies to your gland, what should be done next and on what schedule follows within about 48 hours.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*